Antimicrobial Resistance and Characterization of Helicobacter pylori Strains Isolated from Mexican Adults with Clinical Outcome

References

• International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241.
   Google Scholar
• Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 1997; 25 (5): 973–978.
   PubMed Web of Science ®Google Scholar
• Graham DY, Adam E, Reddy GT et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci 1991; 36 (8): 1084–1088.
   PubMed Web of Science ®Google Scholar
• Mitchell HM, Li YY, Hu PJ et al. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 1992; 166 (1): 149–153.
   PubMed Web of Science ®Google Scholar
• Perez-Perez GI, Taylor DN, Bodhidatta L et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990; 161 (6): 1237-1241.
   Google Scholar
• Torres J, Leal-Herrera Y, Perez-Perez G et al. A com-munity-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178 (4): 1089-1094.
   Google Scholar
• Lopez-Carrillo L, Lopez-Cervantes M, Robles-Diaz G et al. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 2003; 106 (2): 277-282.
   Google Scholar
• de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ 2000; 320 (7226): 31–34.
   PubMed Web of Science ®Google Scholar
• Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995; 333 (15): 984–991.
   PubMed Web of Science ®Google Scholar
• Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol 2001; 13 Suppl 2:S3–S7.
   PubMed Web of Science ®Google Scholar
• de Wit NJ, Mendive J, Seifert B, Cardin F, Rubin G. Guidelines on the management of H. pylori in primary care: development of an implementation strategy. Fam Pract 2000; 17 Suppl 2:S27-S32.
   Google Scholar
• Hunt RH, Fallone CA, Thomson AB. Canadian Helicobacter pylori Consensus Conference update: infections in adults. Canadian Helicobacter Study Group. Can J Gastroenterol 1999; 13 (3): 213–217.
   PubMed Web of Science ®Google Scholar
• Sherman P, Hassall E, Hunt RH, Fallone CA, Veldhuyzen VZ, Thomson AB. Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents. Can J Gastroenterol 1999; 13 (7): 553–559.
   PubMed Web of Science ®Google Scholar
• Kato S, Fujimura S, Udagawa H et al. Antibiotic resis-tance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002; 40 (2): 649-653.
   PubMed Web of Science ®Google Scholar
• Adamek RJ, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin—influence on treatment outcome. Am J Gastroenterol 1998; 93 (3): 386–389.
   PubMed Web of Science ®Google Scholar
• Gotoh A, Kawakami Y, Akahane T et al. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol Immunol 1997; 41 (1): 7-12.
   Google Scholar
• Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115 (5): 1272–1277.
   PubMed Web of Science ®Google Scholar
• Debets-Ossenkopp YJ, Reyes G, Mulder J et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003; 51 (1): 141-145.
   Google Scholar
• Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998; 115 (5): 1278–1282.
   PubMed Web of Science ®Google Scholar
• Megraud F. Resistance of Helicobacter pylori to antibi-otics. Aliment Pharmacol Ther 1997; 11 Suppl 1: 43–53.
   PubMed Web of Science ®Google Scholar
• Megraud F, Lehn N, Lind T et al. Antimicrobial suscep-tibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999; 43 (11): 2747-2752.
   Google Scholar
• Ryan KA, van Doom n LJ, Moran AP, Glennon M, Smith T, Maher M. Evaluation of clarithromycin resistance and cagA and yacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays. J Clin Microbiol 2001; 39 (5): 1978-1980.
   Google Scholar
• Torres J, Camorlinga-Ponce M, Perez-Perez G et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J Clin Microbiol 2001; 39 (7): 2677-2680.
   PubMed Web of Science ®Google Scholar
• Garza-Gonzalez E, Perez-Perez GI, Alanis-Aguilar O, Tijerina-Menchaca R, Maldonado-Garza HJ, Bosques-Padilla FJ. Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico. J Chemother 2002; 14 (4): 342–345.
   PubMed Web of Science ®Google Scholar
• Burucoa C, Lhomme V, Fauchere JL. Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates: experimental results and meta-analysis. J Clin Microbiol 1999; 37 (12): 4071–4080.
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20 (10): 1161-1181.
   Google Scholar
• Laur'en P. The two histological main types of gastric carcinoma diffuse and so-calles intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31–49.
   Google Scholar
• Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17 (12): 3835-3849.
   Google Scholar
• Engstrand L, Nguyen AM, Graham DY, el Zaatari FA. Reverse transcription and polymerase chain reaction amplifica-tion of rRNA for detection of Helicobacter species. J Clin Microbiol 1992; 30 (9): 2295-2301.
   Google Scholar
• Atherton JC, Cao P, Peek RM, Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alle-les of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270 (30): 17771–17777.
   Google Scholar
• Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991; 29 (9): 2072–2075.
   PubMed Web of Science ®Google Scholar
• Fontana C, Favaro M, MineIli S et al. New site of mod-ification of 23S rRNA associated with clarithromycin resis-tance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002; 46 (12): 3765-3769.
   Google Scholar
• Fontana C, Favaro M, Pietroiusti A, Pistoia ES, Galante A, Favalli C. Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J Clin Microbiol 2003; 41 (8): 3636–3640.
   PubMed Web of Science ®Google Scholar
• Broutet N, Marais A, Lamouliatte H et al. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J Clin Microbiol 2001; 39 (4): 1319-1322.
   PubMed Web of Science ®Google Scholar
• van Doom 11, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, de Boer WA. Importance of Helicobacter pylori cagA and yacA status for the efficacy of antibiotic treat-ment. Gut 2000; 46 (3): 321-326.
   Google Scholar
• Lui SY, Yeoh KG, Ho B. Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonul-cer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J Clin Microbiol 2003; 41 (11): 5011–5014.
   PubMed Web of Science ®Google Scholar
• Herrera-Goepfert R, Arista-Nasr J, Alba-Campomanes A. Pathologic features of the gastric mucosa adjacent to pri-mary MALT-lymphomas. J Clin Gastroenterol 1999; 29 (3): 266–269.
   PubMed Web of Science ®Google Scholar